Arkolith/Insider Trading/ANEB/Form 4

English Aron R.

Director, 10% OwnerAnebulo Pharmaceuticals, Inc. (ANEB) · full profile →Form 4 · filed Dec 26, 2024
Net Buying
Open-Market Buys
$10.0M
Open-Market Sells
$0
Net Open-Market Flow
$10.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2024Buy(P)10.1M$0.99$10.0M15.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-052101) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML